Ngā hua rapu - Heidi Schwarzenbach
- E whakaatu ana i te 1 - 20 hua o te 31
- Haere ki te Whārangi Whai Ake
-
1
Circulating nucleic acids as biomarkers in breast cancer mā Heidi Schwarzenbach
I whakaputaina 2013Revisão -
2
-
3
Circulating DNA as biomarker in breast cancer mā Heidi Schwarzenbach, Klaus Pantel
I whakaputaina 2015Revisão -
4
-
5
-
6
Exosomes in Immune Regulation mā Heidi Schwarzenbach, Peter B. Gahan
I whakaputaina 2021Revisão -
7
Interplay between LncRNAs and microRNAs in Breast Cancer mā Heidi Schwarzenbach, Peter B. Gahan
I whakaputaina 2023Revisão -
8
-
9
Data Normalization Strategies for MicroRNA Quantification mā Heidi Schwarzenbach, Andreia Silva, George A. Călin, Klaus Pantel
I whakaputaina 2015Revisão -
10
Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases mā Simon A. Joosse, Volkmar Müller, Bettina Steinbach, Klaus Pantel, Heidi Schwarzenbach
I whakaputaina 2014Artigo -
11
-
12
Aberrant plasma levels of circulating<i>miR-16, miR-107, miR-130a</i>and<i>miR-146a</i>are associated with lymph node metastasis and receptor status of breast cancer patients mā Isabel Stückrath, Brigitte Rack, Wolfgang Janni, Bernadette Jäger, Klaus Pantel, Heidi Schwarzenbach
I whakaputaina 2015Artigo -
13
Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression mā Heidi Schwarzenbach, Corinna Eichelser, Jolanthe Kropidlowski, Wolfgang Janni, Brigitte Rack, Klaus Pantel
I whakaputaina 2012Artigo -
14
Circulating Mitochondrial DNA as Biomarker Linking Environmental Chemical Exposure to Early Preclinical Lesions Elevation of mtDNA in Human Serum after Exposure to Carcinogenic Hal... mā Lygia Therese Budnik, Stefan Kloth, Xaver Baur, Alexandra M. Preisser, Heidi Schwarzenbach
I whakaputaina 2013Artigo -
15
-
16
Deregulated Serum Concentrations of Circulating Cell–Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression mā Corinna Eichelser, Dieter Flesch‐Janys, Jenny C. Chang, Klaus Pantel, Heidi Schwarzenbach
I whakaputaina 2013Artigo -
17
Impact of platinum‐based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients mā Pauline Wimberger, Carina Roth, Klaus Pantel, Sabine Kasimir‐Bauer, Rainer Kimmig, Heidi Schwarzenbach
I whakaputaina 2010Artigo -
18
Low Levels of Cell-Free Circulating miR-361-3p and miR-625* as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors mā Carina Roth, Isabel Stückrath, Klaus Pantel, Jakob R. Izbicki, Michael Tachezy, Heidi Schwarzenbach
I whakaputaina 2012Artigo -
19
Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer mā Xiaodan Meng, Volkmar Müller, Karin Milde‐Langosch, Fabian Trillsch, Klaus Pantel, Heidi Schwarzenbach
I whakaputaina 2016Artigo -
20
Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients mā Corinna Eichelser, Isabel Stückrath, Volkmar Müller, Karin Milde‐Langosch, Harriet Wikman, Klaus Pantel, Heidi Schwarzenbach
I whakaputaina 2014Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Gene
Cancer
Medicine
Internal medicine
microRNA
Cancer research
Genetics
Oncology
Biochemistry
Breast cancer
Bioinformatics
Metastasis
Pathology
Microvesicles
Biomarker
Circulating tumor cell
Immunology
Liquid biopsy
Ovarian cancer
Apoptosis
Cell biology
Exosome
Surgical oncology
Chemistry
Computational biology
DNA
Downregulation and upregulation
Gene expression
Lymph node